Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: A comparison of behavioral, acquisition-risk based, and economic metrics

2026/03/17 by Minttu M. Rönn, Athena P. Kourtis, Yizhi Liang +11 · 1 voice
Economics, Econometrics and Finance · Medicine · #HIV, Drug Use, Sexual Risk #HIV/AIDS Impact and Responses #HIV/AIDS Research and Interventions

paper · doi:10.1016/j.annepidem.2026.110079

openalex publication_date 2026/03/17 · crossref created 2026/03/17 · openalex created_date 2026/03/18 · crossref deposited 2026/04/23 · crossref indexed 2026/04/23 · crossref issued 2026/06/01 · crossref published 2026/06/01 · crossref published-print 2026/06/01 · openalex updated_date 2026/08/01

Discussions

• Interested in learning more? Click here: doi.org/10.1016/j.an... [bsky, 0 points, 0 comments]